Combined PI3K/Akt and Hsp90 Targeting Synergistically Suppresses Essential Functions of Alloreactive T Cells and Increases Tregs

Journal of Leukocyte Biology - United States
doi 10.1189/jlb.5a0814-413r
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Trail Over-Expression on Donor T Cells Enhances GVT and Suppresses GVHD by Inhibiting Alloreactive T Cells and Impairing Host APC Functions

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2004English

MicroRNA-101 Inhibits Growth and Metastasis of Human Ovarian Cancer Cells by Targeting PI3K/AKT

Archives of Medical Science
Medicine
2019English

JTC-801 Suppresses Melanoma Cells Growth Through the PI3K‑Akt‑mTOR Signaling Pathways

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

BCL6B Suppresses Proliferation and Migration of Colorectal Carcinoma Cells Through Inhibition of the PI3K/AKT Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Expression of TNFRSF25 on Conventional T Cells and Tregs

Journal of Clinical Investigation
Medicine
2011English

Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering With HSP90-EGFR Interaction and Downstream Signaling Pathways

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

Combining BET and HDAC Inhibitors Synergistically Induces Apoptosis of Melanoma and Suppresses AKT and YAP Signaling

Oncotarget
Oncology
2015English

Alantolactone Suppresses Human Osteosarcoma Through the PI3K/AKT Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy